Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss state of the pharmaceutical landscape, future of drug pricing, drug ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Why is the U.S. at risk of losing its measles elimination status? And what did top CMS official Mehmet Oz tell hospital ...

The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

An Aim stalwart for decades, Hutchmed (HCM) has often suffered by association, whether it is the generally depressed ...

Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...

Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative ...

Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...